Kiran Musunuru and Rebecca Ahrens-Nicklas

Time Magazine·Feb 11

This story is reported by Time Magazine. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Children’s Hospital of Philadelphia Secures Five-year, up to $38.9 Million ARPA-H Award to Advance Personalized Gene Editing Therapies

Children's Hospital of Philadelphia·18h ago

2

Kiran Musunuru and Rebecca Ahrens-Nicklas: The 100 Most Influential People of 2026

Time Magazine·Apr 15

3

Healthcare Leadership Awards 2026: Dr. Kiran Musunuru and Dr. Rebecca Ahrens-Nicklas

The Business Journals·Jun 18

4

The Story of Baby KJ

The Washington Post·Jun 9

5

CHOP, Penn doctors behind lifesaving gene-editing therapy named TIME's 100 Most Influential People of 2026

CBS News·Apr 19

6

“It Was Not a Cure”: Musunuru Cautions ASGCT on Baby KJ Promise

Genetic Engineering and Biotechnology News·May 13

7

Researchers Behind World’s First Patient-Tailored CRISPR Gene Editing Therapy Named to TIME100 List of the 100 Most Influential People in the World

Children's Hospital of Philadelphia·Apr 15

8

Baby KJ scientists hit speed bump in quest to scale custom gene editor

STAT·Mar 31